According to reports, more than 70% of patients with autoimmune diseases such as systemic lupus erythematosus have autoantibodies against histone H2B (67), which also explains the increased risk of thromboembolism in patients with autoimmune diseases. The gene discussed is H2BC12L; the disease is autoimmune disease.